Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Jul 1;153(7):660-665.
doi: 10.1001/jamadermatol.2017.0298.

Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches

Affiliations
Observational Study

Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches

Michelle A Bongiorno et al. JAMA Dermatol. .

Abstract

Importance: Patients with tuberous sclerosis complex (TSC) frequently develop collagenous connective tissue nevi. The prototypical lesion is a large shagreen patch located on the lower back, but some patients only manifest small collagenomas or have lesions elsewhere on the body. The ability to recognize these variable presentations can be important for the diagnosis of TSC.

Objective: To describe the clinical characteristics of connective tissue nevi on the trunk and extremities of patients with tuberous sclerosis complex.

Design, setting, and participants: A retrospective analysis of patient medical records and skin photography was performed; 104 adult patients with TSC were enrolled in an observational cohort study that was enriched for those with pulmonary lymphangioleiomyomatosis, and was therefore composed mostly of women (99 women, 5 men). All patients included were examined at the National Institutes of Health (NIH) in Bethesda, Maryland, from 1998 to 2013. Connective tissue nevi were categorized per anatomic location and size. Lesions less than 1 cm in diameter were termed collagenomas. Shagreen patches were characterized as small (1 to <4 cm), medium (4 to <8 cm), and large (≥8 cm).

Main outcome and measures: Frequency, anatomic location, size, and histological appearance of connective tissue nevi in patients with TSC.

Results: Overall, 58 of 104 patients (median [range] age, 42 [19-70] years) with TSC (56%) had at least 1 connective tissue nevus on the trunk or thighs; of these, 28 of 58 patients (48%) had a solitary lesion, and 30 of 58 patients (52%) had 2 or more lesions. Overall, 120 lesions from 55 patients were classified by size; 46 lesions (38%) were collagenomas; 39 lesions (32%) were small shagreen patches; 21 lesions (18%), medium shagreen patches; and 14 lesions (12%), large shagreen patches. The distribution of lesions was 9% (n = 11), upper back; 29% (n = 35), middle back; 51% (n = 61), lower back; and 11% (n = 13), other locations. All 26 shagreen patches that were analyzed histopathologically had coarse collagen fibers and 24 of 26 stained with Miller elastic stain had decreased elastic fibers. On immunoblot analysis, fibroblasts grown from shagreen patches expressed higher levels of phosphorylated ribosomal protein S6 than paired fibroblasts from normal-appearing skin.

Conclusions and relevance: Tuberous sclerosis complex-related connective tissue nevi are not limited to the lower back, and occasionally present on the central or upper back, buttocks, or thighs. Elastic fibers are typically decreased. Recognition of these variable presentations can be important for TSC diagnosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Gross Clinical Appearance of Connective Tissue Nevi in Tuberous Sclerosis Complex
A, Multiple collagenomas on the lower back; B, a small shagreen patch on the mid back; C, a shagreen patch composed of 2 medium-sized lesions on the lower back; and D, a large shagreen patch on the left posterior thigh.
Figure 2.
Figure 2.. Distribution of Connective Tissue Nevi in Tuberous Sclerosis Complex
A, Composite of 100 lesions that were mapped from photographs. Grey represents lesions on the posterior surface; blue represents lesions on anterior surface. B, Number and corresponding percentages of tuberous sclerosis complex (TSC)-related connective tissue nevi found on various regions of the posterior trunk based on photographs or clinical records. The total lesion count was 120, including 2 lesions on the anterior trunk and 4 lesions on the thighs for which percentages are not shown.
Figure 3.
Figure 3.. Histological Appearance of Shagreen Patch
A, Hematoxylin-eosin stain shows thickened, disorganized collagen bundles in the reticular dermis (original magnification ×40). B, Elastin stain shows little elastin in connective tissue nevi (original magnification ×40).
Figure 4.
Figure 4.. Immunoblot Analysis of Skin Tumor and Control Fibroblasts From Patients With TSC
Patients are indicated as P numbers. Immunoblotting is shown for TSC2, TSC1, pS6, S6, and β-actin. AF indicates angiofibroma cells; C, control fibroblasts; FCP, fibrous cephalic plaque cells; PF, periungual fibroma cells; pS6, phospho-S6 (Ser-235/236); S6, ribosomal protein S6; SP, shagreen patch cells.

Similar articles

Cited by

  • Animals in Dermatology.
    Pandit VS, Yelhanka RR. Pandit VS, et al. Indian J Dermatol. 2024 Jul-Aug;69(4):333-337. doi: 10.4103/ijd.ijd_502_23. Epub 2024 Aug 19. Indian J Dermatol. 2024. PMID: 39296695 Free PMC article. No abstract available.
  • Segmental Collagenoma in Tuberous Sclerosis - Think Beyond the Skin: A Rare Case Report.
    Nagarajan AK, Manoharan K, Moozhiyil S. Nagarajan AK, et al. Indian J Dermatol. 2023 Jan-Feb;68(1):123. doi: 10.4103/ijd.ijd_1038_20. Indian J Dermatol. 2023. PMID: 37151256 Free PMC article.
  • Fibrous cephalic plaques in tuberous sclerosis complex.
    Oyerinde O, Buccine D, Treichel A, Hong C, Lee CR, Moss J, Darling TN. Oyerinde O, et al. J Am Acad Dermatol. 2018 Apr;78(4):717-724. doi: 10.1016/j.jaad.2017.12.027. Epub 2017 Dec 16. J Am Acad Dermatol. 2018. PMID: 29258863 Free PMC article.
  • Miliary fibromas in tuberous sclerosis complex.
    Cartron AM, Buccine D, Treichel AM, Lee CR, Moss J, Darling TN. Cartron AM, et al. J Eur Acad Dermatol Venereol. 2021 May;35(5):1226-1229. doi: 10.1111/jdv.17161. Epub 2021 Feb 23. J Eur Acad Dermatol Venereol. 2021. PMID: 33565654 Free PMC article.
  • Collagenoma of the Eyelid.
    Purgert RJ, Blandford AD, Schowalter MK, Piliang MP, Hwang CJ, Perry JD. Purgert RJ, et al. Ophthalmic Plast Reconstr Surg. 2019 Mar/Apr;35(2):e29-e30. doi: 10.1097/IOP.0000000000001298. Ophthalmic Plast Reconstr Surg. 2019. PMID: 30624411 Free PMC article.

References

    1. Roach ES. Applying the lessons of tuberous sclerosis: the 2015 Hower Award lecture. Pediatr Neurol. 2016;63:6-22. - PubMed
    1. Darling TN, Moss J, Mausner M Dermatologic Manifestations of Tuberous Sclerosis Complex. In: Kwiatkowski DJ, Whittemore VH, Thiele EA, eds. Tuberous Sclerosis Complex: Genes, Clinical Features, and Therapeutics. Weinheim, Germany: WILEY-VCH Verlag GmbH & Co. KGaA;2010:285-309.
    1. Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group . Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243-254. - PMC - PubMed
    1. Teng JM, Cowen EW, Wataya-Kaneda M, et al. . Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex consensus statements. JAMA Dermatol. 2014;150(10):1095-1101. - PMC - PubMed
    1. Hunt A. Tuberous sclerosis: a survey of 97 cases. II: physical findings. Dev Med Child Neurol. 1983;25(3):350-352. - PubMed

Publication types

Substances

Supplementary concepts